title: [Patients with acute critical pulmonary embolism should be evaluated and treated in a centre with medical and surgical possibilities].
abstract: Acute pulmonary embolism (PE) is a common and potential lifethreatening condition. Nevertheless the advancements in the patient visitation and treatment algorithms have been few and the mortality unchanged high. Acute high risk PE, which is the most serious subtype, is primary treated with trombolysis. This treatment is not always possible or sufficient. Recent studies have shown that surgical embolectomy is a relevant treatment offer with low mortalities of 6-8%. Patients with acute critical PE should be evaluated and treated in a multidisciplinary centre with medical and surgical possibilities.
authors.affiliation: Thoraxkirurgisk Klinik, Hjertecentret, Afsnit 2152, Rigshospitalet, Blegdamsvej 9, 2100 København Ø, Denmark. lehnert@dadlnet.dk
authors.forename: Per
authors.initials: P
authors.lastname: Lehnert
authors.forename: Christian H
authors.initials: CH
authors.lastname: Møller
authors.forename: Jørn
authors.initials: J
authors.lastname: Carlsen
authors.forename: Peer
authors.initials: P
authors.lastname: Grande
authors.forename: Jann
authors.initials: J
authors.lastname: Mortensen
authors.forename: Daniel A
authors.initials: DA
authors.lastname: Steinbrüchel
mesh_terms: D000208:Acute Disease; D000075202:Contraindications; D017128:Embolectomy; D005343:Fibrinolytic Agents / Q000627:therapeutic use; D006493:Heparin / Q000627:therapeutic use; D006801:Humans; D011655:Pulmonary Embolism / Q000145:classification / Q000188:drug therapy / Q000473:pathology / Q000601:surgery*; D012306:Risk; D012720:Severity of Illness Index; D015912:Thrombolytic Therapy
chemical_list: D005343:Fibrinolytic Agents; D006493:Heparin